Developing Online Interventions to Reduce Stigma-Related Stress, Sexual Health, and HIV Risk Among Young Chinese MSM
Developing Efficient Intervention Technologies to Reduce Stigma-Related Stress, Mental Health Problems, and HIV Risk Among Young Chinese MSM
3 other identifiers
interventional
120
1 country
1
Brief Summary
This study is a 2-arm RCT that will assess the efficacy of a culturally adapted, 10-session SGM-affirmative, internet-based cognitive behavioral therapy (iCBT) among young men who have sex with men (YMSM) in Hunan province China. The affirmative treatment called ESTEEM is based on a minority stress-focused, CBT framework. In collaboration with colleagues at Central South University (CSU), the investigators will assess whether a culturally adapted version of iCBT ESTEEM demonstrates significant reductions in HIV risk behavior and mental health symptoms (e.g., depression, anxiety) compared to self-monitoring of stress and mood.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 13, 2021
CompletedFirst Posted
Study publicly available on registry
January 22, 2021
CompletedStudy Start
First participant enrolled
April 19, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2022
CompletedResults Posted
Study results publicly available
January 17, 2024
CompletedFebruary 16, 2024
February 1, 2024
1.6 years
January 13, 2021
November 14, 2023
February 13, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Number of Past 90-Day Condomless Anal Sex Acts
The Timeline Follow-Back (TLFB) assesses retrospective estimates of HIV-related sexual behavior in the past 30 days. The TLFB was originally developed in interview format, but has been adapted as online self-report questionnaire. Participants report on daily partner type (e.g. main, casual), type of sexual behavior (e.g. insertive anal sex, receptive anal sex, oral sex), and condom use. The TLFB has good test-retest reliability, convergent validity, and agreement with collateral reports for HIV-related sexual behavior. Administration time ranges from 10-30 minutes. For this primary outcome measure, condomless anal sex (CAS) with main or casual partners will be determined. The primary comparison will be change in the number of CAS acts from baseline to 8 months post-baseline.
Baseline, 4 months, 8 months
Secondary Outcomes (17)
Change in Number of Past 90-Day Condomless Anal Sex Acts With Casual Partners
Baseline, 4 months, 8 months
Change in Depression
Baseline, 4 months, 8 months
Change in Anxiety
Baseline, 4 months, 8 months
Change in Disordered Alcohol Use
Baseline, 4 months, 8 months
Change in Disordered Drug Use
Baseline, 4 months, 8 months
- +12 more secondary outcomes
Other Outcomes (3)
Change in Depression Severity
Baseline, 4 months, 8 months
Change in Anxiety Severity
Baseline, 4 months, 8 months
Change in Self-Esteem
Baseline, 4 months, 8 months
Study Arms (2)
ESTEEM iCBT
EXPERIMENTALThe online CBT treatment consists of 10 weekly modules that participants will complete over the course of 10 weeks.
Self-monitoring
PLACEBO COMPARATORParticipants will be asked to indicate their past 7-day mood; stress experiences; and mental and behavioral health on an online survey experience once per week for 10 weeks
Interventions
The online CBT treatment consists of 10 weekly modules that participants will complete over the course of 10 weeks.
Participants will be asked to indicate their past 7-day mood; stress experiences; and mental and behavioral health on an online survey experience once per week for 10 weeks
Eligibility Criteria
You may qualify if:
- years old
- Live in Hunan province China
- Current gender identity as male
- Report past 12-month sex with men
- Be confirmed HIV-negative upon at-home testing
- Report past 3-month condomless/PrEP-less anal sex
- Past-week symptoms of depression or anxiety using the Brief Symptom Inventory-4 cutoff of 2.5 on either the depression subscale, anxiety subscale, or both
- No past 3-month mental health services of more than 2 visits per month
- Weekly access to internet on a laptop, desktop, or tablet device
- Ability to read, write, and speak in Mandarin
- Provision of informed consent
You may not qualify if:
- Current active suicidality or homicidality (defined as active intent or concrete plan, as opposed to passive ideation)
- Evidence of active and untreated mania or psychosis that could interfere with the participant's ability to volitionally consent to research or interfere with their ability to safely and reliably complete research
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Yale Universitylead
- National Institute of Mental Health (NIMH)collaborator
- Central South Universitycollaborator
- Fogarty International Center of the National Institute of Healthcollaborator
Study Sites (1)
Central South University
Hunan, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
This trial was conducted during the COVID-19 pandemic and associated restrictive policies in China, which might have influenced intervention efficacy in ways unknown, although stress, mental health, and behavioral outcomes such as HIV-transmission-risk behavior have all been documented to have been influenced by the pandemic
Results Point of Contact
- Title
- Dr. Dani Chiaramonte
- Organization
- Yale
Study Officials
- PRINCIPAL INVESTIGATOR
John Pachankis, Ph.D.
Yale University
Publication Agreements
- PI is Sponsor Employee
- Yes
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 13, 2021
First Posted
January 22, 2021
Study Start
April 19, 2021
Primary Completion
November 30, 2022
Study Completion
November 30, 2022
Last Updated
February 16, 2024
Results First Posted
January 17, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
- Time Frame
- Data will be available 12 months after study completion for three years.
- Access Criteria
- Data access requests from qualified academic investigators for non-commercial research interests will be reviewed by study investigators. Requestors will be required to sign a data access agreement.
De-identified individual participant data for all primary and secondary outcome measures will be made available.